IFPMA 2015 interview series ‘Why taking flu shot should be your business’
Dr Abraham M. Palache, Influenza Scientist, Consultant at Abbott Biologicals and IFPMA Influenza Vaccine Supply International Task Force, talks about the importance of taking the flu shot. It is all about breaking misconceptions spread by anti-vaxxers. People most at risk should be given priority in receiving the flu shot. Find out who those most at risk are in this interview.
Among infectious diseases, flu is considered a leading killer. On average, worldwide, seasonal epidemics are said to result in some 3 to 5 million cases of severe illness, and about half a million deaths, according to the World Health Organization (WHO).
About IFPMA
IFPMA represents the innovative pharmaceutical industry at the international level, engaging in official relations with the United Nations and multilateral organizations. Our vision is to ensure that scientific progress translates into the next generation of medicines and vaccines that deliver a healthier future for people everywhere.
ifpma.org
To achieve this, we act as a trusted partner, bringing our members' expertise to champion pharmaceutical innovation, drive policy that supports the research, development, and delivery of health technologies, and create sustainable solutions that advance global health.
